Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

Market Cap	28.01B
Revenue (ttm)	25.86B
Net Income (ttm)	1.34B
Shares Out	3.80M
EPS (ttm)	n/a
PE Ratio	20.85
Forward PE	n/a
Dividend	75.00 (1.02%)
Ex-Dividend Date	Dec 29, 2025

Volume	5,948
Average Volume	8,359
Open	6,960.00
Previous Close	7,000.00
Day's Range	6,960.00 - 7,180.00
52-Week Range	6,940.00 - 10,570.00
Beta	0.48
RSI	52.20
Earnings Date	Nov 13, 2025

About KOSDAQ:036480

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1966
• Employees: 134
• Stock Exchange: KOSDAQ
• Ticker Symbol: 036480

Financial Performance

In 2024, KOSDAQ:036480's revenue was 23.80 billion, a decrease of -6.88% compared to the previous year's 25.56 billion. Losses were -1.77 billion, 160.3% more than in 2023.